Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
« Previous Article | Table of Contents | Next Article »
Stroke. 2000;31:601-609

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Investigators, T. A. i. I. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Investigators, T. A. i. I. S.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Blood Thinners
*Stroke
Related Collections
Right arrow Emergency treatment of Stroke
Right arrow Antiplatelets
Right arrow Platelets

(Stroke. 2000;31:601.)
© 2000 American Heart Association, Inc.

Original Contributions

Abciximab in Acute Ischemic Stroke

A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study

The Abciximab in Ischemic Stroke Investigators

From the Department of Neurology, University of Iowa, Iowa City, and the Department of Neurology, CHUV, Lausanne, Switzerland.

Correspondence to H.P. Adams, Jr, MD, Department of Neurology, University of Iowa, Iowa City, IA 52242-1053. E-mail julien.bogousslavsky{at}chuv.hospvd.ch

Background and Purpose—Abciximab is a potent parenterally administered platelet glycoprotein IIb/IIIa antagonist. Because this agent has been shown to improve outcomes in coronary artery disease, there is interest to evaluate whether it could improve cerebral perfusion and outcomes after ischemic stroke. This study was designed to evaluate the safety of abciximab in acute ischemic stroke and to obtain pilot efficacy data.

Methods—We conducted a randomized, double-blind, placebo-controlled, dose-escalation trial. Seventy-four eligible and consenting patients presenting within 24 hours after ischemic stroke onset at 38 study sites were randomly allocated to receive either an escalating dose of abciximab (54 patients) or placebo (20 patients) in a ratio of 3:1. We studied 4 escalating doses of abciximab. Patients underwent a scheduled follow-up head CT scan 24 to 36 hours after the completion of study agent administration to monitor for bleeding complications and were evaluated through 3 months.

Results—There were no cases of major intracranial hemorrhage. Asymptomatic parenchymal hemorrhages were detected on post–study agent CT in 4 of 54 abciximab patients (7%) and in 1 of 20 placebo patients (5%). Six additional abciximab patients had asymptomatic hemorrhagic lesions detected by unscheduled brain imaging during their follow-up period. Nine of 11 patients with asymptomatic hemorrhage had a baseline National Institutes of Health Stroke Scale score >14. At 3 months, there was a trend toward a higher rate of minimal residual disability (Barthel Index >=95 or modified Rankin scale <=1) among abciximab patients compared with those who received placebo.

Conclusions—Abciximab appears to be safe when administered up to 24 hours after stroke onset, and it might improve functional outcome.


Key Words: platelet aggregation inhibitors • randomized controlled trials • stroke, ischemic




This article has been cited by other articles:


Home page
 StrokeHome page
A. Ois, E. Cuadrado-Godia, A. Rodriguez-Campello, J. Jimenez-Conde, and J. Roquer
High Risk of Early Neurological Recurrence in Symptomatic Carotid Stenosis
Stroke, August 1, 2009; 40(8): 2727 - 2731.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Neuroradiol.Home page
R.G. Nogueira, L.H. Schwamm, and J.A. Hirsch
Endovascular Approaches to Acute Stroke, Part 1: Drugs, Devices, and Data
AJNR Am. J. Neuroradiol., April 1, 2009; 30(4): 649 - 661.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
H. P. Adams Jr, E. C. Leira, J. C. Torner, E. Barnathan, L. Padgett, M. B. Effron, W. Hacke, and for the AbESTT-II Investigators
Treating Patients With 'Wake-Up' Stroke: The Experience of the AbESTT-II Trial
Stroke, December 1, 2008; 39(12): 3277 - 3282.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
M. J. O'Donnell, G. J. Hankey, and J. W. Eikelboom
Antiplatelet Therapy for Secondary Prevention of Noncardioembolic Ischemic Stroke: A Critical Review
Stroke, May 1, 2008; 39(5): 1638 - 1646.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
H. P. Adams Jr, M. B. Effron, J. Torner, A. Davalos, J. Frayne, P. Teal, J. Leclerc, B. Oemar, L. Padgett, E. S. Barnathan, et al.
Emergency Administration of Abciximab for Treatment of Patients With Acute Ischemic Stroke: Results of an International Phase III Trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II)
Stroke, January 1, 2008; 39(1): 87 - 99.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
H. P. Adams Jr, G. del Zoppo, M. J. Alberts, D. L. Bhatt, L. Brass, A. Furlan, R. L. Grubb, R. T. Higashida, E. C. Jauch, C. Kidwell, et al.
Guidelines for the Early Management of Adults With Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists.
Circulation, May 22, 2007; 115(20): e478 - e534.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
H. P. Adams Jr, G. del Zoppo, M. J. Alberts, D. L. Bhatt, L. Brass, A. Furlan, R. L. Grubb, R. T. Higashida, E. C. Jauch, C. Kidwell, et al.
Guidelines for the Early Management of Adults With Ischemic Stroke: A Guideline From the American Heart Association/ American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists
Stroke, May 1, 2007; 38(5): 1655 - 1711.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
N. Sprigg, P. M. Bath, L. Zhao, M. R. Willmot, L. J. Gray, M. F. Walker, M. S. Dennis, and N. Russell
Granulocyte-Colony-Stimulating Factor Mobilizes Bone Marrow Stem Cells in Patients With Subacute Ischemic Stroke: The Stem Cell Trial of Recovery EnhanceMent After Stroke (STEMS) Pilot Randomized, Controlled Trial (ISRCTN 16784092)
Stroke, December 1, 2006; 37(12): 2979 - 2983.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
P. Mandava, J. A. Anderson, and T. A. Kent
MRI-guided, open trial of abciximab for ischemic stroke within a 3- to 24-hour window
Neurology, April 11, 2006; 66(7): 1132 - 1132.
[Full Text] [PDF]

Home page
 StrokeHome page
P. A. Ringleb
Thrombolytics, Anticoagulants, and Antiplatelet Agents
Stroke, February 1, 2006; 37(2): 312 - 313.
[Full Text] [PDF]

Home page
 RadiologyHome page
R. J. Seitz, S. Meisel, P. Weller, U. Junghans, H.-J. Wittsack, and M. Siebler
Initial Ischemic Event: Perfusion-weighted MR Imaging and Apparent Diffusion Coefficient for Stroke Evolution
Radiology, December 1, 2005; 237(3): 1020 - 1028.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
K. Umemura, H. Tsukada, T. Kakiuchi, N. Yamada, and H. Matsuura
PET Study of the Neuroprotective Effect of TRA-418, an Antiplatelet Agent, in a Monkey Model of Stroke
J. Nucl. Med., November 1, 2005; 46(11): 1931 - 1936.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
P. D. Mitsias, M. Lu, B. Silver, D. Morris, J. R. Ewing, S. Daley, C. Lewandowski, A. Katramados, N. I. Papamitsakis, H. B. Ebadian, et al.
MRI-guided, open trial of abciximab for ischemic stroke within a 3- to 24-hour window
Neurology, August 23, 2005; 65(4): 612 - 615.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Neuroradiol.Home page
R. I. Aviv, R. O'Neill, M. C. Patel, and I. R. Colquhoun
Abciximab in Patients with Ruptured Intracranial Aneurysms
AJNR Am. J. Neuroradiol., August 1, 2005; 26(7): 1744 - 1750.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
Abciximab Emergent Stroke Treatment Trial Investi
Emergency Administration of Abciximab for Treatment of Patients With Acute Ischemic Stroke: Results of a Randomized Phase 2 Trial
Stroke, April 1, 2005; 36(4): 880 - 890.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
M. S. Hussain, A. Shuaib, and Z. A. Siddiqi
Spinal cord transient ischemic attacks: A possible role for abciximab
Neurology, February 22, 2005; 64(4): 761 - 762.
[Full Text] [PDF]

Home page
 Am. J. Neuroradiol.Home page
T. H. Lee, D. H. Kim, B.-H. Lee, H. J. Kim, C. H. Choi, K. P. Park, D. S. Jung, S. Kim, and T. Y. Moon
Preliminary Results of Endovascular Stent-Assisted Angioplasty for Symptomatic Middle Cerebral Artery Stenosis
AJNR Am. J. Neuroradiol., January 1, 2005; 26(1): 166 - 174.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Neuroradiol.Home page
S. Steiner-Boker, M. Cejna, C. Nasel, E. Minar, and C. W. Kopp
Successful Revascularization of Acute Carotid Stent Thrombosis by Facilitated Thrombolysis
AJNR Am. J. Neuroradiol., September 1, 2004; 25(8): 1411 - 1413.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
C. S. Weaver, J. Leonardi-Bee, F. J. Bath-Hextall, and P. M.W. Bath
Sample Size Calculations in Acute Stroke Trials: A Systematic Review of Their Reporting, Characteristics, and Relationship With Outcome
Stroke, May 1, 2004; 35(5): 1216 - 1224.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
S. Straub, U. Junghans, V. Jovanovic, H. J. Wittsack, R. J. Seitz, and M. Siebler
Systemic Thrombolysis With Recombinant Tissue Plasminogen Activator and Tirofiban in Acute Middle Cerebral Artery Occlusion
Stroke, March 1, 2004; 35(3): 705 - 709.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Neuroradiol.Home page
C. Mounayer, M. Piotin, S. Baldi, L. Spelle, and J. Moret
Intraarterial Administration of Abciximab for Thromboembolic Events Occurring during Aneurysm Coil Placement
AJNR Am. J. Neuroradiol., November 1, 2003; 24(10): 2039 - 2043.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
R. J. Seitz, M. Hamzavi, U. Junghans, P. A. Ringleb, C. Schranz, and M. Siebler
Thrombolysis With Recombinant Tissue Plasminogen Activator and Tirofiban in Stroke: Preliminary Observations
Stroke, August 1, 2003; 34(8): 1932 - 1935.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
R. T. Higashida and A. J. Furlan
Trial Design and Reporting Standards for Intra-Arterial Cerebral Thrombolysis for Acute Ischemic Stroke
Stroke, August 1, 2003; 34 (8): e109 - e137.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
U. Junghans and M. Siebler
Cerebral Microembolism Is Blocked by Tirofiban, a Selective Nonpeptide Platelet Glycoprotein IIb/IIIa Receptor Antagonist
Circulation, June 3, 2003; 107(21): 2717 - 2721.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
M. Fisher
Recommendations for Advancing Development of Acute Stroke Therapies: Stroke Therapy Academic Industry Roundtable 3
Stroke, June 1, 2003; 34(6): 1539 - 1546.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
H. P. Adams Jr, R. J. Adams, T. Brott, G. J. del Zoppo, A. Furlan, L. B. Goldstein, R. L. Grubb, R. Higashida, C. Kidwell, T. G. Kwiatkowski, et al.
Guidelines for the Early Management of Patients With Ischemic Stroke: A Scientific Statement From the Stroke Council of the American Stroke Association
Stroke, April 1, 2003; 34(4): 1056 - 1083.
[Full Text] [PDF]

Home page
 StrokeHome page
M. Fisher and T. G. Brott
Emerging Therapies for Acute Ischemic Stroke: New Therapies on Trial
Stroke, February 1, 2003; 34(2): 359 - 361.
[Full Text] [PDF]

Home page
 Am. J. Neuroradiol.Home page
M. J. Workman, H. J. Cloft, F. C. Tong, J. E. Dion, M. E. Jensen, W. F. Marx, and D. F. Kallmes
Thrombus Formation at the Neck of Cerebral Aneurysms during Treatment with Guglielmi Detachable Coils
AJNR Am. J. Neuroradiol., October 1, 2002; 23(9): 1568 - 1576.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
J. P. Broderick and W. Hacke
Treatment of Acute Ischemic Stroke: Part I: Recanalization Strategies
Circulation, September 17, 2002; 106(12): 1563 - 1569.
[Full Text] [PDF]

Home page
 NeurologyHome page
B. M. Coull, L. S. Williams, L. B. Goldstein, J. F. Meschia, D. Heitzman, S. Chaturvedi, K. C. Johnston, S. Starkman, L. B. Morgenstern, J. L. Wilterdink, et al.
Anticoagulants and antiplatelet agents in acute ischemic stroke: Report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a Division of the American Heart Association)
Neurology, July 9, 2002; 59(1): 13 - 22.
[Full Text] [PDF]

Home page
 StrokeHome page
A. I. Qureshi, M. Saad, O. O. Zaidat, J. I. Suarez, M. J. Alexander, M. Fareed, K. Suri, Z. Ali, and L. N. Hopkins
Intracerebral Hemorrhages Associated With Neurointerventional Procedures Using a Combination of Antithrombotic Agents Including Abciximab
Stroke, July 1, 2002; 33(7): 1916 - 1919.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
B.M. Coull, L.S. Williams, L.B. Goldstein, J.F. Meschia, D. Heitzman, S. Chaturvedi, K.C. Johnston, S. Starkman, L.B. Morgenstern, J.L. Wilterdink, et al.
Anticoagulants and Antiplatelet Agents in Acute Ischemic Stroke: Report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a Division of the American Heart Association)
Stroke, July 1, 2002; 33(7): 1934 - 1942.
[Full Text] [PDF]

Home page
 StrokeHome page
B. Eckert, C. Koch, G. Thomalla, J. Roether, and H. Zeumer
Acute Basilar Artery Occlusion Treated With Combined Intravenous Abciximab and Intra-arterial Tissue Plasminogen Activator: Report of 3 Cases
Stroke, May 1, 2002; 33(5): 1424 - 1427.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Neuroradiol.Home page
O-K. Kwon, K. J. Lee, M. H. Han, C.-W. Oh, D. H. Han, and Y. C. Koh
Intraarterially Administered Abciximab as an Adjuvant Thrombolytic Therapy: Report of Three Cases
AJNR Am. J. Neuroradiol., March 1, 2002; 23(3): 447 - 451.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
R. Hofmann, K. Kerschner, C. Steinwender, A. Kypta, D. Bibl, and F. Leisch
Abciximab Bolus Injection Does Not Reduce Cerebral Ischemic Complications of Elective Carotid Artery Stenting: A Randomized Study
Stroke, March 1, 2002; 33(3): 725 - 727.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
U. Junghans, R. J. Seitz, A. Ritzl, H.-J. Wittsack, G. R. Fink, H.-J. Freund, and M. Siebler
Ischemic brain tissue salvaged from infarction by the GP IIb/IIIa platelet antagonist tirofiban
Neurology, February 12, 2002; 58(3): 474 - 476.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Neuroradiol.Home page
H. J. Cloft, O. B. Samuels, F. C. Tong, and J. E. Dion
Use of Abciximab for Mediation of Thromboembolic Complications of Endovascular Therapy
AJNR Am. J. Neuroradiol., October 1, 2001; 22(9): 1764 - 1767.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. Huang, D. B. Agus, C. J. Winfree, S. Kiss, W. J. Mack, R. A. McTaggart, T. F. Choudhri, L. J Kim, J Mocco, D. J. Pinsky, et al.
Dehydroascorbic acid, a blood-brain barrier transportable form of vitamin C, mediates potent cerebroprotection in experimental stroke
PNAS, September 25, 2001; 98(20): 11720 - 11724.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
E. Houdart, F. Woimant, R. Chapot, C. Mounayer, C. Soria, and J.-J. Merland
Thrombolysis of extracranial and intracranial arteries after IV abciximab
Neurology, June 12, 2001; 56(11): 1582 - 1584.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
K. Y. Lee, J. H. Heo, S. I. Lee, and P. H. Yoon
Rescue treatment with abciximab in acute ischemic stroke
Neurology, June 12, 2001; 56(11): 1585 - 1587.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
K. Uchino, D. Billheimer, and S. C. Cramer
Entry Criteria and Baseline Characteristics Predict Outcome in Acute Stroke Trials
Stroke, April 1, 2001; 32(4): 909 - 916.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Neuroradiol.Home page
E. COMMITTEE OF THE ASITN
Intraarterial Thrombolysis: Ready for Prime Time?
AJNR Am. J. Neuroradiol., January 1, 2001; 22(1): 55 - 58.
[Full Text] [PDF]

Home page
 ASH Education BookHome page
T. A. Waldmann, R. Levy, and B. S. Coller
Emerging Therapies: Spectrum of Applications of Monoclonal Antibody Therapy
Hematology, January 1, 2000; 2000(1): 394 - 408.
[Abstract] [Full Text] [PDF]


Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search
Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited.